InMode Operating Income Over Time
| INMD Stock | USD 14.30 0.06 0.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out InMode Performance and InMode Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could InMode diversify its offerings? Factors like these will boost the valuation of InMode. Market participants price InMode higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every InMode data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.64) | Earnings Share 1.43 | Revenue Per Share | Quarterly Revenue Growth 0.061 | Return On Assets |
InMode's market price often diverges from its book value, the accounting figure shown on InMode's balance sheet. Smart investors calculate InMode's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since InMode's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between InMode's value and its price as these two are different measures arrived at by different means. Investors typically determine if InMode is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMode's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare InMode and related stocks such as Tandem Diabetes Care, Iradimed, and Axogen Inc Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNDM | (24.2 M) | (24.2 M) | (33 M) | (49.4 M) | (75.7 M) | (69 M) | (78.1 M) | (62.9 M) | (44.6 M) | (16.7 M) | (8 M) | 22.7 M | (92.8 M) | (233.2 M) | (99.1 M) | (89.2 M) | (93.7 M) |
| IRMD | 1.4 M | 1.4 M | 1.4 M | 2.8 M | 3.1 M | 11.5 M | 10.9 M | 1.3 M | 6 M | 8.6 M | (756.1 K) | 9.8 M | 15.6 M | 20 M | 22 M | 26.1 M | 27.5 M |
| AXGN | 500 K | (7 M) | (7.8 M) | (9.6 M) | (9.8 M) | (9.3 M) | (8.1 M) | (8 M) | (20.5 M) | (31.4 M) | (23.2 M) | (25.4 M) | (29.7 M) | (21.5 M) | (3.3 M) | (3 M) | (3.1 M) |
| IART | (6 M) | 54.9 M | 73.8 M | (3.6 M) | 65.5 M | 79.6 M | 115.3 M | 44.8 M | 111 M | 93.8 M | 151.4 M | 197.2 M | 238.9 M | 111.5 M | 28.4 M | 32.7 M | 31 M |
| CTEV | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 427.5 M | 368.2 M | (131.8 M) | 386.1 M | (362.7 M) | 162 M | (1.4 B) | (1.3 B) | (1.2 B) |
| AHCO | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | (690) | (1.2 M) | 29.4 M | 71.3 M | 225.6 M | 190.4 M | (598.4 M) | 263.7 M | 237.4 M | 249.2 M |
| OPK | (2.2 M) | (23.2 M) | (37.3 M) | (79.6 M) | (145.8 M) | (98.5 M) | (73.3 M) | (276.4 M) | (171.2 M) | (274.1 M) | 57.7 M | 18.8 M | (226.3 M) | (157 M) | (152.1 M) | (136.9 M) | (130 M) |
| OCS | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (12.3 M) | (13.2 M) | (32.4 M) | (80.7 M) | (73.2 M) | (65.9 M) | (69.2 M) |
| ANAB | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | 4.9 M | (3.3 M) | (3 M) | (28.8 M) | (66.7 M) | (107.4 M) | (23.9 M) | (56.8 M) | (115.2 M) | (164.4 M) | (114.9 M) | (103.5 M) | (98.3 M) |
| XNCR | (9.5 M) | (9.5 M) | (6.2 M) | (10.5 M) | (16.5 M) | (18.3 M) | 22.5 M | (53.6 M) | (79.4 M) | 13.8 M | (76.8 M) | 43.8 M | (82.5 M) | (138.6 M) | (178.4 M) | (160.6 M) | (152.5 M) |
InMode and related stocks such as Tandem Diabetes Care, Iradimed, and Axogen Inc Operating Income description
Operating Income is the amount of profit realized from InMode operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of InMode is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| InMode | INMD |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Tavor Building, Yokneam, |
| Exchange | NASDAQ Exchange |
USD 14.3
Check out InMode Performance and InMode Correlation. For information on how to trade InMode Stock refer to our How to Trade InMode Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
InMode technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.